- Home
- / Lee's Pharm
Lee's Pharm
Stock Price
$1.2
2024-10-29
Market Capitalization
$706.6 M
2024-10-29
Revenue
$1.4 B
FY, 2025
Lee's Pharm Summary
Company Summary
- Overview
- Lee's Pharm (Lee's Pharmaceutical Holdings) is a company that develops, manufactures, and sells biopharmaceutical products for cardiovascular and infectious diseases areas. It also provides a range of products with a focus on dermatology, oncology, gynecology, ophthalmology, pediatrics, rare diseases, and other sectors.
- Type
- Public
- Status
- Active
- Founded
- 1994
- HQ
- Hong Kong, HK | view all locations
- Website
- https://www.leespharm.com
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Leelalertsuphakun Wanee, Executive Director, Managing Director, Chief Marketing & Sales Officer
Li Xiaoyi, Non-Executive Director, Founder
Chan Yau Ching, Independent Non-Executive Director
Operating MetricsView all
Products on the Market
25
Jun, 2023
International Partners
30
Jun, 2023
Technology Platforms
3
Jun, 2023
LocationsView all
2 locations detected
Hong Kong, New Territories HQ
Hong Kong
Building 20E, Phase 3, Hong Kong Science Park, Shatin
Taipei, Taipei City
Taiwan
No.36, Songren Road
Lee's Pharm Financials
Summary Financials
- Revenue (FY, 2025)
- $1.4B
- Gross profit (FY, 2025)
- $934.0M
- Net income (FY, 2025)
- $50.6M
- Cash (FY, 2025)
- $349.9M
- EBIT (FY, 2025)
- $91.9M
- Enterprise value
- $667.0M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026